Synergistic Monitoring System for Drug-Impaired Subjects
Legal Citation
Summary of the Inventive Concept
A novel system integrating EEG, IoT, blockchain, and AI technologies to monitor and analyze physiological signals of subjects under the influence of drugs, providing a more accurate and secure drug profile.
Background and Problem Solved
The original patent addressed the critical issue of monitoring subjects under the influence of drugs, but it had limitations in terms of data security, decentralized storage, and advanced analytics. The new inventive concept overcomes these limitations by synergistically combining distinct technologies to create a more powerful system.
Detailed Description of the Inventive Concept
The Synergistic Monitoring System comprises a wearable IoT device collecting physiological signals, a blockchain-based data storage module ensuring secure data transmission, and a machine learning module utilizing AI algorithms to analyze the signals and predict a drug profile. The system can be integrated with various sensors, including EEG, EMG, oxygenation, and heart rate sensors, to provide a comprehensive picture of the subject's physiological state. The AI-powered analytics enable the identification of patterns in physiological signals, generating a personalized drug profile for each subject.
Novelty and Inventive Step
The new claims introduce the innovative combination of EEG, IoT, blockchain, and AI technologies, which provides a more accurate, secure, and decentralized system for monitoring subjects under the influence of drugs. The inventive step lies in the synergistic integration of these distinct technologies, enabling a more comprehensive and personalized approach to drug profiling.
Alternative Embodiments and Variations
Alternative embodiments may include the use of different types of sensors, such as implantable or ingestible sensors, or the integration of additional AI algorithms for more advanced analytics. Variations may also include the development of specialized systems for specific types of drugs or patient populations.
Potential Commercial Applications and Market
The Synergistic Monitoring System has significant commercial potential in the healthcare and pharmaceutical industries, particularly in the areas of drug abuse treatment, clinical research, and personalized medicine. The system's ability to provide accurate and secure drug profiling can improve patient outcomes, reduce healthcare costs, and enhance the development of new treatments.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical monitoring systems, specifically drug monitoring technologies involving physiological signal processing, biosensors, and medical data analytics
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical technology specialist with expertise in sensor design, signal processing, machine learning, and healthcare monitoring systems, holding advanced degrees in bioengineering or related fields
Obviousness Rationale
A PHOSITA would recognize that integrating IoT, blockchain, and AI technologies into existing drug monitoring systems represents a predictable technological evolution that addresses known limitations in data security, analysis precision, and real-time monitoring capabilities. The fundamental approach of collecting physiological signals for drug profiling remains consistent with the source patent, while the proposed variations merely introduce contemporary technological enhancements. These modifications would be considered routine optimization and combination of known techniques within the medical monitoring domain.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,334 |
|---|---|
| Title | Systems and methods for monitoring a subject under the influence of drugs |
| Assignee(s) | The General Hospital Corporation |